Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

INOVIQ Ltd

IIQ.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia Micro Cap Analyst: N/A

Last Close

$0.13

▲ +5.88%

Market Cap $18.29M · Vol 237.53K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$18.29M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

47.37

Momentum

Beta

1.73

vs Market

52W High

$0.40

67.04% below

52W Low

$0.12

9.09% above

Volume

237.53K

Avg 121.60K

P/B

4.06

Price-to-book

ROE

82.00%

Return on equity

Free Float

66.05%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, INOVIQ Ltd (IIQ.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does IIQ.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.70%

-10.00%

-42.86%

-46.27%

YTD

-53.55%

-53.85%

-68.71%

-86.91%

Financials & Valuation

TTM · Annual

Total Revenue	$575.55K
Net Income	$-5,192,777.00
Revenue Growth (YoY)	-16.34%
Gross Margin	-37.82%
Operating Margin	-1,114.00%
Net Profit Margin	-902.24%
ROE	82.00%
ROA · ROIC	-38.58% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	86.46
P/B	4.06
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	140.78M

Technical Indicators

50-Day SMA	$0.14
200-Day SMA	$0.22
RSI (14)	47.37
Beta	1.73
52-Week High	$0.40
52-Week Low	$0.12

Volume Today	237.53K
Avg Daily Volume (30D)	121.60K
Relative Volume	1.95x
Volatility (10D)	64.08
Volatility (30D)	56.92
Free Float	66.05%

Analyst Consensus

N/A

Current Price $0.13

Mean Target N/A

52W Low$0.12 52W High$0.40

Current

Target

$0.12 $0.40

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001S5Y1G8

ISINAU0000196149

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Company -0.11% JNJ Johnson & Johnson -0.27% ABBV AbbVie Inc. +1.63% NVS Novartis AG +0.00% NOVN.S Novartis AG +0.43%

Company Profile

INOVIQ Ltd is an Australia-based biotechnology company developing diagnostics and therapeutics for cancer. The Company's commercialized products include EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The Company is also advancing clinical-stage diagnostics for the detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumors.